2017 American Transplant Congress Archives

2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

α-Lipoc Acid Improve the Short Term Outcomes in Human Liver Transplantation.

P. Casciato,¹ N. Ambrosi,² C. Fiorella,² M. Vasquez,¹ A. Gadano,¹ M. de Santibañes,¹ E. de Santibañes,¹ M. Zandomeni,¹ M. Chahdi,¹ J. Laquinandi,¹ P. Santofimia Castaño,³ J. Iovanna,³ E. Chuluyan,² C. Incardona.⁴
“Donor Age or Quality” a Qualitative Analysis of Livers Declined for 830.

M. Dokus, E. DeAngelis, G. Ramaraju, K. Tomiyama, J. Huang, M. Levstik, R. Hernandez-Alejandro, M. Orloff, R. Kashyap.
Apolipoprotein L1 & Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.

J. Locke,¹ D. Sawinski,² R. Reed,¹ B. Shelton,¹ P. MacLennan,¹ V. Kumar,¹ S. Mehta,¹ R. Mannon,¹ R. Gaston,¹ B. Julian,¹ J. Carr,³ J. Terry,³ M. Kilgore,¹ A. Massie,⁴ D. Segev,⁴ C. Lewis.¹
Clostridium difficile Infection in Intestinal Transplant Recipients.

V. Goldenberg,¹ A. Berbel,² J. Camargo,¹ J. Simkins.¹
De Novo Donor-Specific Antibodies After Allograft Nephrectomy.

G. Lucisano,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² N. Gunby,² S. Hassan,¹ A. Gueret-Wardle,¹ M. Willicombe,¹ D. Taube.¹
De Novo Donor-Specific Antibody Formation After Kidney Retransplant Is Associated with Specificity Against Class I.

K. Atiemo,¹ B. Ho,¹ H. Bhagat,² E. Lee,^2,3 A. Daud,¹ R. Kang,¹ S. Montag,^1,4 L. Zhao,^1,4 J. Schwartz,² D. Ladner.¹
De Novo Use of Everolimus Reduces Late-Onset Cytomegalovirus Primary Disease Occurring After Antiviral Prophylaxis Discontinuation in Kidney Transplant Recipients.

A. Devresse,¹ V. Avettand-Fenoel,² A. Scemla,³ L. Morin,³ X. Lebreton,³ C. Tinel,³ L. Amrouche,³ L. Lamhaut,⁴ M.-O. Timsit,⁵ J. Zuber,³ C. Legendre,³ D. Anglicheau.³
De-Novo Portal Vein Thrombosis After Adult-to-Adult Living Donor Liver Transplantation (LDLT) Does Not Impact on Long-Term Outcome.

I. Linares,¹ N. Goldaracena,¹ R. Rosales,¹ L. De La Maza,¹ J. Echeverri,¹ M. Kaths,¹ D. Kollman,¹ N. Selzner,² S. McCluskey,³ G. Sapisochin,¹ L. Lilly,² P. Greig,¹ M. Bhat,² A. Ghanekar,¹ M. Cattral,¹ I. McGilvray,¹ D. Grant,¹ M. Selzner.¹
Ex Vivo Normothermic Perfusion of Isolated Segmental Porcine Bowel: A Novel Functional Model of the Small Intestine.

M. Hamed,¹ A. Barlow,¹ S. Khosla,¹ A. Sagar,¹ F. Gribble,² M. Murphy,³ G. Pettigrew,¹ E. Bolton,¹ J. Bradley,¹ M. Nicholson,¹ S. Hosgood,¹ K. Saeb-Parsy.¹
In Vitro Optimisation of the Immunotherapeutic Effects of Umbilical Cord Derived MSC.

S. de Witte,¹ A. Merino,¹ M. Franquesa,¹ T. Strini,¹ J. van Zoggel,¹ S. Korevaar,¹ F. Luk,¹ M. Gargesha,⁴ D. Roy,⁴ S. Elliman,² P. Newsome,³ C. Baan,¹ M. Hoogduijn.¹

2017 American Transplant Congress

α-Lipoc Acid Improve the Short Term Outcomes in Human Liver Transplantation.

“Donor Age or Quality” a Qualitative Analysis of Livers Declined for 830.

Apolipoprotein L1 & Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.

Clostridium difficile Infection in Intestinal Transplant Recipients.

De Novo Donor-Specific Antibodies After Allograft Nephrectomy.

De Novo Donor-Specific Antibody Formation After Kidney Retransplant Is Associated with Specificity Against Class I.

De Novo Use of Everolimus Reduces Late-Onset Cytomegalovirus Primary Disease Occurring After Antiviral Prophylaxis Discontinuation in Kidney Transplant Recipients.

De-Novo Portal Vein Thrombosis After Adult-to-Adult Living Donor Liver Transplantation (LDLT) Does Not Impact on Long-Term Outcome.

Ex Vivo Normothermic Perfusion of Isolated Segmental Porcine Bowel: A Novel Functional Model of the Small Intestine.

In Vitro Optimisation of the Immunotherapeutic Effects of Umbilical Cord Derived MSC.